A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/13 (2006.01) A61K 31/155 (2006.01) A61P 27/08 (2006.01)
Patent
CA 2466516
A method for preventing retinal ganglion cell depth, associated with glaucoma, in an animal of the mammalian species, including humans, comprising the step of administering to ganglion cells and their axons (optic nerve) of said mammal a pharmaceutical composition which comprises as its active ingredient one or more compounds having activity for blocking a reverse mode of the sodium/calcium exchanger.
Cette invention se rapporte à un procédé servant à prévenir la mort cellulaire des ganglions de la rétine associée au glaucome, chez un mammifère, notamment chez l'homme, ce procédé consistant à administrer aux cellules des ganglions et à leurs axones (nerf optique) de ce mammifère une composition pharmaceutique qui comprend comme principe actif un ou plusieurs composés ayant pour effet de bloquer le mode inverse de l'échangeur sodium/calcium.
Adorante Joseph S.
Ehring George R.
Kopper Kara L.
Allergan Inc.
Gowling Lafleur Henderson Llp
LandOfFree
Targeting the reverse mode of the na+/ca2+ exchanger for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Targeting the reverse mode of the na+/ca2+ exchanger for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Targeting the reverse mode of the na+/ca2+ exchanger for the... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1591565